(RMS) Hermes International SCA - Ratings and Ratios
Leather Goods, Ready-To-Wear, Accessories, Silk Textiles, Watches, Perfume
Description: RMS Hermes International SCA
Hermès International SCA is a luxury goods conglomerate with a diverse portfolio of high-end products, including leather goods, ready-to-wear, accessories, silk and textiles, art of living, and beauty products. The companys product range is characterized by exceptional craftsmanship, quality, and attention to detail, justifying its premium pricing and loyal customer base.
With a global presence across multiple regions, including Europe, Japan, Asia Pacific, the Americas, and the Middle East, Hermès operates a network of stores, including specialized boutiques for watches, perfumes, and tableware. The companys vertical integration, encompassing weaving, engraving, printing, dyeing, and finishing, enables control over the production process, ensuring consistency and quality.
Key performance indicators (KPIs) for Hermès include revenue growth, gross margin, and operating profit margin. The companys strong brand reputation and loyal customer base contribute to its pricing power, with a gross margin consistently above 65%. Hermès return on equity (RoE) of 43.98% indicates exceptional profitability, driven by its ability to maintain high prices and control costs. The companys price-to-earnings (P/E) ratio of 52.36 suggests a premium valuation, reflecting its strong brand, growth prospects, and high profitability.
To further analyze Hermès performance, other relevant KPIs include sales per square meter, inventory turnover, and brand strength metrics, such as customer retention and Net Promoter Score (NPS). The companys ability to maintain its luxury image and exclusivity, while expanding its global presence, will be crucial in driving future growth and profitability.
RMS Stock Overview
| Market Cap in USD | 259,880m |
| Sub-Industry | Apparel, Accessories & Luxury Goods |
| IPO / Inception |
RMS Stock Ratings
| Growth Rating | 65.7% |
| Fundamental | 86.1% |
| Dividend Rating | 60.9% |
| Return 12m vs S&P 500 | -14.0% |
| Analyst Rating | - |
RMS Dividends
| Dividend Yield 12m | 1.18% |
| Yield on Cost 5y | 3.76% |
| Annual Growth 5y | 40.60% |
| Payout Consistency | 97.0% |
| Payout Ratio | 37.5% |
RMS Growth Ratios
| Growth Correlation 3m | -56.3% |
| Growth Correlation 12m | 37.6% |
| Growth Correlation 5y | 94.2% |
| CAGR 5y | 24.71% |
| CAGR/Max DD 5y | 0.59 |
| Sharpe Ratio 12m | 0.59 |
| Alpha | -15.71 |
| Beta | 0.839 |
| Volatility | 30.19% |
| Current Volume | 60.6k |
| Average Volume 20d | 52.3k |
| Stop Loss | 2061.2 (-3%) |
| Signal | 0.03 |
Piotroski VR‑10 (Strict, 0-10) 6.5
| Net Income (6.85b TTM) > 0 and > 6% of Revenue (6% = 1.39b TTM) |
| FCFTA 0.41 (>2.0%) and ΔFCFTA 23.53pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 48.18% (prev 80.62%; Δ -32.44pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.45 (>3.0%) and CFO 9.83b > Net Income 6.85b (YES >=105%, WARN >=100%) |
| Net Debt (-8.26b) to EBITDA (10.82b) ratio: -0.76 <= 3.0 (WARN <= 3.5) |
| Current Ratio 4.50 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (105.0m) change vs 12m ago 0.02% (target <= -2.0% for YES) |
| Gross Margin 68.88% (prev 69.99%; Δ -1.11pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 109.8% (prev 65.67%; Δ 44.11pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 112.8 (EBITDA TTM 10.82b / Interest Expense TTM 85.0m) >= 6 (WARN >= 3) |
Altman Z'' 15.71
| (A) 0.51 = (Total Current Assets 14.37b - Total Current Liabilities 3.19b) / Total Assets 21.83b |
| (B) 0.76 = Retained Earnings (Balance) 16.62b / Total Assets 21.83b |
| (C) 0.45 = EBIT TTM 9.59b / Avg Total Assets 21.14b |
| (D) 6.49 = Book Value of Equity 33.85b / Total Liabilities 5.21b |
| Total Rating: 15.71 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 86.06
| 1. Piotroski 6.50pt = 1.50 |
| 2. FCF Yield 4.17% = 2.08 |
| 3. FCF Margin 38.63% = 7.50 |
| 4. Debt/Equity 0.02 = 2.50 |
| 5. Debt/Ebitda 0.03 = 2.50 |
| 6. ROIC - WACC 32.99% = 12.50 |
| 7. RoE 42.68% = 2.50 |
| 8. Rev. Trend 97.90% = 4.89 |
| 9. Rev. CAGR 0.0% = 0.0 |
| 10. EPS Trend 3.11% = 0.08 |
| 11. EPS CAGR 0.0% = 0.0 |
What is the price of RMS shares?
Over the past week, the price has changed by +2.66%, over one month by -11.01%, over three months by -10.75% and over the past year by +1.19%.
Is Hermes International SCA a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of RMS is around 2152.51 EUR . This means that RMS is currently overvalued and has a potential downside of 1.29%.
Is RMS a buy, sell or hold?
What are the forecasts/targets for the RMS price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 2477.5 | 16.6% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 2413 | 13.6% |
RMS Fundamental Data Overview
Market Cap EUR = 223.11b (223.11b EUR * 1.0 EUR.EUR)
CCE Cash And Equivalents = 8.39b EUR (last quarter)
P/E Trailing = 49.6486
P/E Forward = 47.619
P/S = 14.2109
P/B = 13.0839
P/EG = 5.0099
Beta = 0.827
Revenue TTM = 23.20b EUR
EBIT TTM = 9.59b EUR
EBITDA TTM = 10.82b EUR
Long Term Debt = 30.0m EUR (from longTermDebt, last quarter)
Short Term Debt = 336.0m EUR (from shortTermDebt, last quarter)
Debt = 366.0m EUR (Calculated: Short Term 336.0m + Long Term 30.0m)
Net Debt = -8.26b EUR (from netDebt column, last quarter)
Enterprise Value = 215.09b EUR (223.11b + Debt 366.0m - CCE 8.39b)
Interest Coverage Ratio = 112.8 (Ebit TTM 9.59b / Interest Expense TTM 85.0m)
FCF Yield = 4.17% (FCF TTM 8.96b / Enterprise Value 215.09b)
FCF Margin = 38.63% (FCF TTM 8.96b / Revenue TTM 23.20b)
Net Margin = 29.52% (Net Income TTM 6.85b / Revenue TTM 23.20b)
Gross Margin = 68.88% ((Revenue TTM 23.20b - Cost of Revenue TTM 7.22b) / Revenue TTM)
Tobins Q-Ratio = 6.35 (Enterprise Value 215.09b / Book Value Of Equity 33.85b)
Interest Expense / Debt = 7.10% (Interest Expense 26.0m / Debt 366.0m)
Taxrate = 28.68% (from yearly Income Tax Expense: 1.84b / 6.43b)
NOPAT = 6.84b (EBIT 9.59b * (1 - 28.68%))
Current Ratio = 4.50 (Total Current Assets 14.37b / Total Current Liabilities 3.19b)
Debt / Equity = 0.02 (Debt 366.0m / last Quarter total Stockholder Equity 16.60b)
Debt / EBITDA = 0.03 (Net Debt -8.26b / EBITDA 10.82b)
Debt / FCF = 0.04 (Debt 366.0m / FCF TTM 8.96b)
Total Stockholder Equity = 16.05b (last 4 quarters mean)
RoA = 31.38% (Net Income 6.85b, Total Assets 21.83b )
RoE = 42.68% (Net Income TTM 6.85b / Total Stockholder Equity 16.05b)
RoCE = 59.64% (Ebit 9.59b / (Equity 16.05b + L.T.Debt 30.0m))
RoIC = 42.09% (NOPAT 6.84b / Invested Capital 16.25b)
WACC = 9.10% (E(223.11b)/V(223.48b) * Re(9.11%)) + (D(366.0m)/V(223.48b) * Rd(7.10%) * (1-Tc(0.29)))
Shares Correlation 5-Years: 90.0 | Cagr: 0.09%
Discount Rate = 9.11% (= CAPM, Blume Beta Adj.)
[DCF Debug] Terminal Value 78.05% ; FCFE base≈6.81b ; Y1≈8.40b ; Y5≈14.34b
Fair Price DCF = 1910 (DCF Value 200.27b / Shares Outstanding 104.8m; 5y FCF grow 25.0% → 3.0% )
Revenue Correlation: 97.90 | Revenue CAGR: 0.0%
Rev Growth-of-Growth: -1.25
EPS Correlation: 3.11 | EPS CAGR: 0.0%
EPS Growth-of-Growth: -28.65